Coronavirus News Roundup: January 9–January 15
Here are pandemic highlights for the week
Here are pandemic highlights for the week
With a vaccine in limited availability, many still need medicines to keep the virus at bay
Scientists are debating whether to delay, skip or halve doses. But untested tweaks could shake public confidence
This winter the novel coronavirus may kill more people than heart disease, cancer, stroke, Alzheimer’s or diabetes
Researchers race to determine why variants identified in Britain and South Africa spread so quickly and whether they’ll compromise vaccines
Social science offers valuable lessons about ways to convince those who are hesitant about the shots
Gonzalo Moratorio assists his country in steering a more adept response than that mounted in Argentina and Brazil
Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before
The virus flourishes by undermining the body’s chemical defense system
More and more patients are dealing with major symptoms that linger for months
There is evidence the new variant could be more transmissible, yet vaccines work very well against it
A look at apps that predict the chance of infection and illness, depending on what you’re doing and where you are
The missed checkups could result in later, more severe diagnoses down the line
Take a survey and share your experience
Two RNA vaccines will be useful as U.S. infections surge, but the speedy authorizations complicate clinical trials
Deaths are surging, and mental health is strained. But coping strategies people use amid other catastrophes can help
Fears about lingering coronavirus are prompting a massive disinfection initiative before the Bidens move in
Here are pandemic highlights for the week
With the festive season ahead, Nature examines what is known about the risks of COVID spread and how researchers will spend their time off
Emergency use authorizations by the FDA are not ideal
You have free articles left.
Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.